Scarica l'app Stockscreener
78.29
0.03%
-0.02
Pre-mercato:
78.70
0.41
+0.52%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Ani Pharmaceuticals Inc Borsa (ANIP) Ultime notizie
ANI Pharmaceuticals rolls out generic carbamazepine extended-release capsules - MSN
ANI Pharmaceuticals Launches Carbamazepine Extended-Release Capsules - Intellectia AI
ANI Pharmaceuticals launches generic carbamazepine capsules By Investing.com - Investing.com India
Ani Pharmaceuticals’ Cook sells $38k in stock - Investing.com
ANI Pharmaceuticals (NASDAQ:ANIP) VP Meredith Cook Sells 500 Shares - MarketBeat
Ani Pharmaceuticals’ Cook sells $38k in stock By Investing.com - Investing.com South Africa
ANI Pharmaceuticals (ANIP) SVP Meredith Cook sells 500 shares - Stock Titan
ANI Pharmaceuticals launches generic carbamazepine capsules - Investing.com
ANI Pharmaceuticals Announces the Launch of Carbamazepine Extended-Release Capsules - Bitget
ANI Pharma targets $65M U.S. market with new Carbatrol generic - Stock Titan
Is ANI Pharmaceuticals Inc still a buy after recent gainsGDP Growth & Low Risk High Win Rate Picks - baoquankhu1.vn
IBRX Stock Rises 7% on Strong Q1 2026 Preliminary Results - TradingView — Track All Markets
Does ANI Pharmaceuticals' (ANIP) New Cardiovascular Generic Deepen Its Niche Strategy Or Stretch It? - Yahoo Finance
ANI Pharmaceuticals Expands Limited Competition Portfolio With New Cardiovascular Generic - Sahm
ANI Pharmaceuticals Looks Undervalued As Cortrophin Drives Rare Disease Growth - Seeking Alpha
ANIP Stock Price, Quote & Chart | ANI PHARMACEUTICALS INC (NASDAQ:ANIP) - ChartMill
Record 2025 growth at ANI Pharmaceuticals (ANIP) and key 2026 proxy votes - Stock Titan
Zacks.com featured highlights include Intuit, ANI Pharmaceuticals and Gaming and Leisure Properties - Yahoo Finance
Fed Watch: Can ANI Pharmaceuticals Inc lead its sector in growthWeekly Investment Summary & Verified Swing Trading Watchlist - baoquankhu1.vn
ANI Pharmaceuticals Announces FDA Approval and Launch of Isosorbide Mononitrate Tablet - Sahm
Did ILUVIEN’s NEW DAY Trial Publication Just Reframe ANI Pharmaceuticals' (ANIP) Retinal Franchise Narrative? - Sahm
ANI Pharmaceuticals launches generic isosorbide mononitrate tablets By Investing.com - Investing.com India
ANI Pharmaceuticals, Inc. (ANIP) Stock Forecasts - Yahoo! Finance Canada
Ani Pharmaceuticals announces FDA approval and launch of isosorbide mononitrate tablet - marketscreener.com
Ani Pharmaceuticals Announces FDA Approval And Launch Of Isosorbide Mononitrate Tablet - TradingView — Track All Markets
ANI Pharmaceuticals launches generic isosorbide mononitrate tablets - Investing.com
Does ANI Pharmaceuticals Inc stock have upside surprise potentialMarket Growth Report & Short-Term Trading Alerts - baoquankhu1.vn
ANI Pharmaceuticals, Inc. Files Form 8-K Announcing Auditor Change – April 2026 SEC Filing Details - Minichart
ANI Pharmaceuticals Announces Publication of NEW DAY Clinical Trial Results in Ophthalmology - Sahm
Artivion, ANI Pharmaceuticals, and Privia Health Shares Are Soaring, What You Need To Know - Yahoo Finance
Auditor switch at ANI Pharmaceuticals (NASDAQ: ANIP) from EisnerAmper to EY - Stock Titan
ANI Pharmaceuticals (NASDAQ:ANIP) Price Gap Sparks Nasdaq Futures Focus - Kalkine Media
ANI Pharmaceuticals (NASDAQ:ANIP) Shares Gap UpHere's Why - MarketBeat
Here's the Reason ANI Pharmaceuticals (ANIP) Shows Powerful Momentum - Bitget
Here's Why ANI Pharmaceuticals (ANIP) is a Strong Momentum Stock - Yahoo Finance
ANI Pharmaceuticals Publishes NEW DAY Clinical Trial Results for ILUVIEN in Ophthalmology - National Today
ANIP Technical Analysis & Stock Price Forecast - Intellectia AI
ANI Pharmaceuticals, Inc. $ANIP Shares Sold by Aberdeen Group plc - MarketBeat
Diabetic macular edema study on ILUVIEN is now in Ophthalmology - Stock Titan
ANI Pharmaceuticals Inc (ANIP) Trading 3.7% Higher on Apr 6 - GuruFocus
Travel Stocks: Will ANI Pharmaceuticals Inc stock go up in YEAR2026 Big Picture & Real-Time Stock Entry Alerts - baoquankhu1.vn
ANI Pharmaceuticals: Worthy Of A Position - Seeking Alpha
A Look At ANI Pharmaceuticals (ANIP) Valuation After Mixed Short Term Share Price Moves - Sahm
Why ANI Pharmaceuticals (ANIP) Stands Out as a Leading Long-Term Growth Stock - Bitget
Why ANI Pharmaceuticals (ANIP) is a Top Growth Stock for the Long-Term - Yahoo Finance
ANI Pharmaceuticals, Inc. (ANIP) Stock forecasts - Yahoo Finance UK
AGIO Rises on Mitapivat Progress Toward Accelerated Approval in SCD - TradingView — Track All Markets
ANIP Stock Outlook: Cortrophin Growth vs. Retina Reset - TradingView
ANI Pharmaceuticals 2026 Watchlist: Gout Sales Force and Rare Disease - Yahoo Finance
Ultragenyx Pharmaceutical Announces FDA Acceptance of UX016 IND - TradingView — Track All Markets
Volume Recap: Can ANI Pharmaceuticals Inc beat the S P 5002026 Spike Watch & Consistent Return Investment Signals - baoquankhu1.vn
1.06%
1.05%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):